EPISODE · Jan 14, 2026 · 1 MIN
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
from Equity Insider – Daily News Podcast Briefings · host MH Editor
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 14, 2026 — Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt, projected to rocket from $110 billion toward a staggering $225.65 billion by 2032[1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming $170 […] The post Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff appeared first on markets-headlines.
NOW PLAYING
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m